EVERSANA
Pharma Marketing & Medical Communications · Healthcare & Life Sciences Consulting

EVERSANA: Risk & public record

EVERSANA: 373 research papers in five years.

Data updated Nov 22, 2026 · Back to the company report

What the registers and the postings say about this employer.

Legal entity active
Eversana Life Science Services, LLC · dol.gov ↗
Not checked
Postings are real
Alion truth index: B
75/100
Ghost roles
re-checked against its careers site
0%
Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Domain and mail securityeversana.com · Nov 15, 2026
Spoofed mail (DMARC)
Spoofed mail goes to spam, for part of the mail · dns.google ↗
Weak
Who may send its mail (SPF)
Other senders fail (-all) · dns.google ↗
Good
HTTPS certificate
Valid certificate · GoDaddy.com · crt.sh ↗
Good
HTTPS enforced (HSTS)
Not enforced · hstspreload.org ↗
Weak
Security contact (security.txt)
No security.txt · eversana.com ↗
Weak
Encrypted mail delivery (MTA-STS)
No MTA-STS policy · dns.google ↗
Weak
Signed DNS (DNSSEC)
Not signed · dnsviz.net ↗
Weak
Certificate issuers (CAA)
Any authority may issue certificates · dns.google ↗
Weak
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices The domain: its DNS records, its site's headers and certificate.

Public record

EVERSANA: 373 research papers in five years.

Research outputpapers its people wrote, per OpenAlex
373papers in five years
3.9kcitations
Health Systems, Economic Evaluations, Quality of Life
Economics, Econometrics and Finance
203 papers
Statistical Methods in Clinical Trials
Mathematics
55 papers
Meta-analysis and systematic reviews
Decision Sciences
38 papers
Pharmaceutical Economics and Policy
Economics, Econometrics and Finance
35 papers
Multiple Sclerosis Research Studies
Medicine
34 papers

Works most with: Johnson & Johnson (United States), Pfizer (United States), AstraZeneca (United Kingdom), Novartis (Switzerland), Bristol-Myers Squibb (United States), Mayo Clinic

Influence
Employees' political contributions, 2026 cycle
48 contributions · their own money, not the company's; names not shown · fec.gov ↗
$9.7k
Each line links its register: the agency's page, the EU Transparency Register, the FEC, the USPTO, CourtListener.